22157.jpg
CD47 Inhibitor Drug Clinical Trials Market Outlook to 2028 - Emerging CD47 Inhibitor Clinical Trials Showcase Potential Cancer Treatment Breakthroughs
06 sept. 2024 06h48 HE | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering....
Global Pharmacovigilance Market
Pharmacovigilance Market - Global Forecasts from 2024 to 2029: Increased Prevalence of ADRs to Drive Expansion
16 août 2024 07h13 HE | Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmacovigilance Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global pharmacovigilance...
22157.jpg
Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2024: Widening Research Purview - From Cancer to Autoimmune Disorders
04 juil. 2024 04h03 HE | Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Market Report: Featuring Abeome, ABL Bio, Agenus, Akeso Biopharma, AnaptysBio, EpimAb Biotherapeutics, Immutep, Incyte and Y-Biologics
20 juin 2024 04h23 HE | Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In recent...
22157.jpg
Project Management in Drug Development Webinar
13 juin 2024 09h30 HE | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Project Management in Drug Development" training has been added to ResearchAndMarkets.com's offering. Project management is crucial to drug...
22157.jpg
GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
07 juin 2024 03h32 HE | Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. In...
Biom Pharmaceutical Corporation
FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome
08 mai 2024 09h25 HE | Biom Pharmaceutical Corporation
Sarasota, Florida, May 08, 2024 (GLOBE NEWSWIRE) -- BIOM Pharmaceutical Corporation is thrilled to announce that Bi104, its innovative drug product, has been granted orphan-drug designation by the...
22157.jpg
Global CD70 Targeting Therapies Market & Clinical Trials Report 2024 - Insight by Company, Country, Indication & Phase
29 avr. 2024 07h32 HE | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024 - Groundbreaking Advances in PLK Targeted Therapies Promise to Revolutionize Treatment for Cancer and Other Diseases
29 avr. 2024 06h53 HE | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's...
pharmather logo.png
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
16 avr. 2024 08h00 HE | PharmaTher Holdings Ltd.
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its...